ADRB3 gene promoter DNA methylation in blood and visceral adipose tissue is associated with metabolic disturbances in men

Papers of special note have been highlighted as:

• of interest

•• of considerable interest

References

• 1 Deloukas P, Kanoni S, Willenborg C et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45(1), 25–33 (2013).
  Medline CASGoogle Scholar
• 2 Hajer GR, van Haeften TW, Visseren FL. Adipose tissue dysfunction in obesity, diabetes, and vascular diseases. Eur. Heart. J. 29(24), 2959–2971 (2008)
  Medline CASGoogle Scholar
• 3 Bouchard C, Rice T, Lemieux S et al. Major gene for abdominal visceral fat area in the Quebec Family Study. Int. J. Obes. Relat. Metab. Disord. 20(5), 420–427 (1996).
  Medline CASGoogle Scholar
• 4 Heller DA, de Faire U, Pedersen NL et al. Genetic and environmental influences on serum lipid levels in twins. N. Engl. J. Med. 328(16), 1150–1156 (1993).
  Medline CASGoogle Scholar
• 5 Teslovich TM, Musunuru K, Smith AV et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307), 707–713 (2010).
  Medline CASGoogle Scholar
• 6 Speliotes EK, Willer CJ, Berndt SI et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42(11), 937–948 (2010). • In this genome-wide association study, 32 loci were strongly associated with BMI in two independent cohorts of approximately 250,000 subjects. This study identified 18 new obesity susceptibility loci that might be involved in human body weight regulation.
  Medline CASGoogle Scholar
• 7 Guay SP, Brisson D, Lamarche B et al. DNA methylation variations at CETP and LPL gene promoter loci: New molecular biomarkers associated with blood lipid profile variability. Atherosclerosis 228(2), 413–420 (2013). • This study showed that DNA methylation variability at the CETP and LPL gene promoter is associated with blood lipid concentration variability. This suggests that CETP and LPL epipolymorphisms might partially explain the missing heritability of blood lipid profile.
  Medline CASGoogle Scholar
• 8 Guay SP, Brisson D, Munger J et al. ABCA1 gene promoter DNA methylation is associated with HDL particle profile and coronary artery disease in familial hypercholesterolemia. Epigenetics 7(5), 464–472 (2012).
  Medline CASGoogle Scholar
• 9 Guay SP, Voisin G, Brisson D et al. Epigenome-wide analysis in familial hypercholesterolemia identified new loci associated with high-density lipoprotein cholesterol concentration. Epigenomics 4(6), 623-439 (2012). •• This study showed that the DNA methylation variability observed at genome-wide levels might contribute significantly to plasma HDL-C concentrations. A number of new candidate genes for the investigation of the molecular bases of dyslipidemia emerged from this study, including the ADRB3 gene.
  Google Scholar
• 10 Talens RP, Jukema JW, Trompet S et al. Hypermethylation at loci sensitive to the prenatal environment is associated with increased incidence of myocardial infarction. Int. J. Epidemiol. 41(1), 106–115 (2012).
  MedlineGoogle Scholar
• 11 Zhang Y, Kent JW 2nd, Lee A et al. Fatty acid binding protein 3 (fabp3) is associated with insulin, lipids and cardiovascular phenotypes of the metabolic syndrome through epigenetic modifications in a northern European family population. BMC Med. Genomics 6, 9 (2013). • The results of this family study suggest that FABP3 DNA methylation levels influence the expression of the metabolic syndrome components and might have important implications for cardiovascular diseases. They also show that the heritability of gene specific DNA methylation levels might be as high as 48%.
  MedlineGoogle Scholar
• 12 Turcot V, Bouchard L, Faucher G et al. DPP4 gene DNA methylation in the omentum is associated with its gene expression and plasma lipid profile in severe obesity. Obesity (Silver Spring) 19(2), 388–395 (2011). •• Shows that DPP4 DNA methylation measured in visceral adipose tissue of severely obese women was significantly associated with obesity-related phenotypes. Particularly, these methylation levels were negatively correlated with DPP4 mRNA levels and were associated with the variability in the plasma lipid profile.
  Medline CASGoogle Scholar
• 13 Kuehnen P, Mischke M, Wiegand S et al. An Alu element-associated hypermethylation variant of the POMC gene is associated with childhood obesity. PLoS Genet. 8, e1002543 (2012). •• This study identified the first epipolymorphisms associated with the susceptibility to obesity. A higher DNA methylation at the third exon of the POMC gene was observed in obese children compared to normal-weight children and was associated with a lower gene expression.
  Medline CASGoogle Scholar
• 14 Marchi M, Lisi S, Curcio M, et al. Human leptin tissue distribution, but not weight loss-dependent change in expression, is associated with methylation of its promoter. Epigenetics 6(10), 1198–1206 (2011).
  Medline CASGoogle Scholar
• 15 Lonnqvist F, Thome A, Nilsell K et al. A pathogenic role of visceral fat beta 3-adrenoceptors in obesity. J. Clin. Invest. 95(3), 1109–1116 (1995).
  Medline CASGoogle Scholar
• 16 Corella D, Guillen M, Portoles O et al. Gender specific associations of the Trp64Arg mutation in the beta3-adrenergic receptor gene with obesity-related phenotypes in a Mediterranean population: interaction with a common lipoprotein lipase gene variation. J. Intern. Med. 250(4), 348–360 (2001).
  Medline CASGoogle Scholar
• 17 Katzmarzyk PT, Perusse L, Bouchard C. Genetics of abdominal visceral fat levels. Am. J. Hum. Biol. 11(2), 225–235 (1999).
  MedlineGoogle Scholar
• 18 Susulic VS, Frederich RC, Lawitts J et al. Targeted disruption of the beta 3-adrenergic receptor gene. J. Biol. Chem. 270(49), 29483–29492 (1995).
  Medline CASGoogle Scholar
• 19 Grujic D, Susulic VS, Harper ME et al. Beta3-adrenergic receptors on white and brown adipocytes mediate beta3-selective agonist-induced effects on energy expenditure, insulin secretion, and food intake. A study using transgenic and gene knockout mice. J. Biol. Chem. 272(28), 17686–17693 (1997).
  Medline CASGoogle Scholar
• 20 Kurokawa N, Young EH, Oka Y et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int. J. Obes. (Lond) 32(8), 1240-1249 (2008). •• This meta-analysis reveals that the ADRB3 p.Trp54Arg mutation might be associated with BMI in East Asians, but not in Europeans. It suggests that a greater susceptibility to obesity and cardiovascular disease caused by ADRB3 deficiency is controversial in Caucasians.
  MedlineGoogle Scholar
• 21 Mirrakhimov AE, Kerimkulova AS, Lunegova OS et al. An association between TRP64ARG polymorphism of the B3 adrenoreceptor gene and some metabolic disturbances. Cardiovas. Diabetol. 10, 89 (2011). • This study found a strong association between the ADRB3 p.Trp64Arg mutation and abdominal obesity and HDL-C levels among others.
  Medline CASGoogle Scholar
• 22 Ringel J, Kreutz R, Distler A et al. The Trp64Arg polymorphism of the beta3-adrenergic receptor gene is associated with hypertension in men with type 2 diabetes mellitus. Am. J. Hypertens. 13(9), 1027–1031 (2000).
  Medline CASGoogle Scholar
• 23 de Luis DA, Aller R, Izaola O et al. Interaction of -55CT polymorphism of UCP3 gene with Trp64Arg polymorphism of beta3adrenoreceptor gene on insulin resistance in obese patients. Eur. Rev. Med. Pharmacol. Sci. 16(5), 610–616 (2012).
  Medline CASGoogle Scholar
• 24 Wang Y, Luk AO, Ma RC et al. Independent predictive roles of eotaxin Ala23Thr, paraoxonase 2 Ser311Cys and beta-adrenergic receptor Trp64Arg polymorphisms on cardiac disease in Type 2 Diabetes–an 8-year prospective cohort analysis of 1297 patients. Diabet. Med. 27(4), 376–383 (2010).
  Medline CASGoogle Scholar
• 25 Gagnon J, Mauriege P, Roy S et al. The Trp64Arg mutation of the beta3 adrenergic receptor gene has no effect on obesity phenotypes in the Quebec Family Study and Swedish Obese Subjects cohorts. J. Clin. Invest. 98(9), 2086–2093 (1996).
  Medline CASGoogle Scholar
• 26 Gaudet D, Arsenault S, Belanger C et al. Procedure to protect confidentiality of familial data in community genetics and genomic research. Clin. Genet. 55(4), 259–264 (1999).
  Medline CASGoogle Scholar
• 27 Lohman T, Roche A, Martorell R. Standardization of anthropometric measurements. In: The Airlie (VA) consensus conference. Lohman T, Roche A, Martorell R (Eds). Human Kinetics 39–80 (1988).
  Google Scholar
• 28 Marceau P, Biron S, Hould FS et al. Duodenal switch improved standard biliopancreatic diversion: a retrospective study. Surg. Obes. Relat. Dis. 5(1), 43–47 (2009).
  MedlineGoogle Scholar
• 29 Bouchard L, Vohl MC, Lebel S et al. Contribution of genetic and metabolic syndrome to omental adipose tissue PAI-1 gene mRNA and plasma levels in obesity. Obes. Surg. 20(4), 492–499 (2010).
  MedlineGoogle Scholar
• 30 Gorzelniak K, Janke J, Engeli S, Sharma AM. Validation of endogenous controls for gene expression studies in human adipocytes and preadipocytes. Horm. Metab. Res. 33(4), 625–627 (2001).
  Medline CASGoogle Scholar
• 31 Cartharius K, Frech K, Grote K, Klocke B et al. MatInspector and beyond: promoter analysis based on transcription factor binding sites. Bioinformatics 21(13), 2933–2942 (2005).
  Medline CASGoogle Scholar
• 32 Movassagh M, Choy MK, Goddard M et al. Differential DNA methylation correlates with differential expression of angiogenic factors in human heart failure. PloS ONE 5, e8564 (2010).
  MedlineGoogle Scholar
• 33 Gellersen B, Kempf R. Human prolactin gene expression: positive correlation between site-specific methylation and gene activity in a set of human lymphoid cell lines. Mol. Endocrinol. 4(12), 1874–1886 (1990).
  Medline CASGoogle Scholar
• 34 Tan CK, Chong HC, Tan EH, Tan NS. Getting ‘Smad’ about obesity and diabetes. Nutr. Diabetes. 2, e29 (2012).
  Medline CASGoogle Scholar
• 35 Ledoux S, Coupaye M, Essig M et al. Traditional anthropometric parameters still predict metabolic disorders in women with severe obesity. Obesity (Silver Spring) 18(5), 1026–1032 (2010).
  MedlineGoogle Scholar
• 36 Kral JG, Buckley MC, Kissileff HR, Schaffner F. Metabolic correlates of eating behavior in severe obesity. Int. J. Obes. Relat. Metab. Disord. 25(2), 258–264 (2001).
  Medline CASGoogle Scholar